Merck & Co., Inc. is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 3 open-market trades across 3 companies since 2016, most recently 2024-03-11.
3 open-market purchases totalling $568.1M since 2016, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.